Search
Now showing items 1-6 of 6
Treatment of low pressure glaucoma and ischemic retinal degeneration with loxapine
(United States. Patent and Trademark Office, 1993-10-12)
The invention relates to a method for increasing blood flow to the retina and choroid in subjects with decreased retinal or choroidal blood flow. The method involves the topical administration of loxapine and is useful for ...
Use of OB-101 to treat inflammation
(United States. Patent and Trademark Office, 1994-09-06)
A novel compound for the treatment and prevention of ocular and other types of inflammation is disclosed. The compound, OB-101, is effective at both the early and late phases of inflammation. The compound is useful for the ...
Treatment of low pressure glaucoma and ischemic retinal degeneration with droperidol
(United States. Patent and Trademark Office, 1993-11-30)
The invention relates to a method for increasing blood flow to the retina and choroid in subjects with decreased retinal or choroidal blood flow. The method involves the topical administration of droperidol and is useful ...
Treating or preventing ocular inflammation or systemic imflammatory disease
(United States. Patent and Trademark Office, 1993-08-31)
A novel compound for controlling (treatment and prevention) of ocular inflammation or systemic inflammatory disease is disclosed. The compound, OB-186, is effective at both the early and late phases of inflammation. The ...
Use of OB-104 to treat ocular inflammation
(United States. Patent and Trademark Office, 1993-03-30)
A novel compound for the treatment and prevention of ocular inflammation is disclosed. The compound, OB-104, is effective at both the early and late phases of inflammation.
Use of OB-101 to treat ocular inflammation
(United States. Patent and Trademark Office, 1993-03-16)
A novel compound for the treatment and prevention of ocular inflammation is disclosed. The compound, OB-101, is effective at both the early and late phases of inflammation. The compound is useful for the treatment of ...